Fraietta, Joseph A.
Lacey, Simon F.
Orlando, Elena J.
Pruteanu-Malinici, Iulian
Gohil, Mercy
Lundh, Stefan
Boesteanu, Alina C.
Wang, Yan
O’Connor, Roddy S.
Hwang, Wei-Ting
Pequignot, Edward
Ambrose, David E.
Zhang, Changfeng
Wilcox, Nicholas
Bedoya, Felipe
Dorfmeier, Corin
Chen, Fang
Tian, Lifeng
Parakandi, Harit
Gupta, Minnal
Young, Regina M.
Johnson, F. Brad http://orcid.org/0000-0002-7443-7227
Kulikovskaya, Irina
Liu, Li
Xu, Jun http://orcid.org/0000-0001-6969-0693
Kassim, Sadik H.
Davis, Megan M.
Levine, Bruce L. http://orcid.org/0000-0001-6971-8465
Frey, Noelle V.
Siegel, Donald L.
Huang, Alexander C.
Wherry, E. John
Bitter, Hans
Brogdon, Jennifer L.
Porter, David L.
June, Carl H. http://orcid.org/0000-0003-0241-3557
Melenhorst, J. Joseph
Article History
Received: 29 September 2017
Accepted: 7 February 2018
First Online: 30 April 2018
Change Date: 5 February 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41591-021-01248-2
Competing interests
: J.A.F., S.F.L., F.B., R.M.Y., B.L.L., J.L.B., D.L.P., C.H.J. and J.J.M. hold patents related to CTL019 cell therapy. These authors declare no additional interests. The remaining authors declare no competing interests.